1. The challenge of indication extrapolation for infliximab biosimilars
2. Enzyme Immunoassays and Radioimmunoassays for Quantification of Anti-TNF Biopharmaceuticals and Anti-Drug Antibodies;Bendtzen,2011
3. Guideline on Immunogenicity Assessment of Biotechnology-Derived Therapeutic Proteinshttp://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2015/10/WC500194507.pdf
4. Guidelines of Evaluation for Similar Biotherapeutics Products (SBPs)http://www.who.int/biologicals/areas/biological_therapeutics/BIOTHERAPEUTICS_FOR_WEB_22APRIL2010.pdf